首页> 外文OA文献 >Health-related quality of life and utility scores in short-term survivors of pediatric acute lymphoblastic leukemia
【2h】

Health-related quality of life and utility scores in short-term survivors of pediatric acute lymphoblastic leukemia

机译:小儿急性淋巴细胞白血病短期幸存者的健康相关生活质量和效用得分

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose: Increase of survival in pediatric acute lymphoblastic leukemia (ALL) has made outcomes such as health-related quality of life (HRQL) and economic burden more important. To make informed decisions on the use of healthcare resources, costs as well as utilities need to be taken into account. Among the preference-based HRQL instruments, the Health Utilities Index (HUI) is the most employed in pediatric cancer. Information on utility scores during ALL treatment and in long-term survivors is available, but utility scores in short-term survivors are lacking. This study assesses utility scores, health state, and HRQL in short-term (6 months to 4 years) ALL survivors. Methods: Cross-sectional single-center cohort study of short-term ALL survivors using HUI3 proxy assessments. Results: Thirty-three survivors (median 1.5 years off treatment) reported 14 unique health states. The majority of survivors (61 %) enjoyed a perfect health, but 21 % had three affected attributes. Overall, HRQL was nonsignificantly lower compared to the norm, although the difference was large and may be clinically relevant. Cognition was significantly impaired (p = 0.03). Conclusion: Although 61 % of short-term survivors of ALL report no impairment, the health status of the other patients lead to a clinically important impaired HRQL compared to norms. Prospective studies assessing utility scores associated with pediatric ALL should be performed, enabling valid and reliable cost-utility analyses for policy makers to make informed decisions. © 2012 The Author(s).
机译:目的:提高小儿急性淋巴细胞白血病(ALL)的生存率已使诸如健康相关的生活质量(HRQL)和经济负担等结局变得更为重要。为了对医疗资源的使用做出明智的决定,需要考虑成本和公用事业。在基于首选项的HRQL仪器中,健康实用程序指数(HUI)在小儿癌症中使用最多。关于ALL治疗期间和长期存活者的效用得分的信息是可获得的,但是缺乏短期存活者的效用得分。这项研究评估短期(6个月至4年)所有幸存者的效用评分,健康状况和HRQL。方法:使用HUI3代理评估对短期ALL幸存者进行横断面单中心队列研究。结果:33名幸存者(中位治疗期为1.5年)报告了14种独特的健康状况。大多数幸存者(61%)享有完美的健康状况,但21%的人具有三个受影响的属性。总体而言,尽管差异很大并且可能与临床相关,但HRQL与正常水平相比没有显着降低。认知能力明显受损(p = 0.03)。结论:尽管61%的ALL短期幸存者未表现出损害,但与正常人相比,其他患者的健康状况导致HRQL发生临床上重要的损害。应进行前瞻性研究,评估与儿科ALL相关的效用评分,以使决策者能够进行有效而可靠的成本效用分析,以做出明智的决策。 ©2012作者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号